Cancer pain
Conditions
Interventions
Experimental group:Advanced cancer pain was treated with morphine and tipredone orally
control group:Only morphine was taken orally to treat cancer pain
Sponsors
Yunnan First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Cancer pain patients with middle and advanced tumors who need to receive drug analgesia; 2. Patients who can tolerate morphine therapy; 3. Patients who can be treated with tepredone;
Exclusion criteria
Exclusion criteria: 1. Patients with multiple organ failure who cannot tolerate drug treatment; 2. Patients allergic to morphine and tipredone; 3. Patients with a history of long-term opioid use or drug abuse; 4. Patients who are unwilling to cooperate; 5. Other patients with special medical history who are not suitable for this study; 6. Patients who are taking an increased adverse reaction due to interaction with the experimental drug; 7. Patients allergic to the experimental drug; 8. Patients with other conditions deemed unsuitable for participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale;Daily dose of morphine;Karnofsky Performance Scale; | — |
Countries
China
Contacts
Public ContactJin Hua
Yunnan First People's Hospital
Outcome results
None listed